Back to R2 link
Top Industry News
- HAS Consultation On Transition Period For Industry To Provide Gmp Evidence For Drug Substance Manufacturers
- FDA Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products
- Saudi Food and Drug Authority Issues Technical Regulation on Wheat Flour
- MHRA Export Drugs and Medicines: Special Rules
- Philippine FDA Starts Consultation on Rules and Regulations on Registration Applications
- ANVISA Approves Regulatory Result Assessment (ARR)
- AICIS: Authorisation Required for DecaBDE and PFOA-Related Compounds from 21 July 2023
- MHRA In Vitro Diagnostic Medical Devices: Guidance On Legislation
- Europe Guidance for the Transition of Clinical Trials from the Clinical Trials Directive to the Clinical Trials Regulation
- HAS Public Consultation On The Proposed Regulation For Active Ingredients Under The Health Products Act
- MHRA Implementation of Medical Devices Future Regime
- Canada Issues Prohibition of Certain Toxic Substances Regulations, 2022
- FDA Qualification of Medical Device Development Tools
- Philippines FDA Issues Public Health Warnings Against Unregistered Food Products
- FDA Guidance for Industry: FDA's Voluntary Qualified Importer Program